WEKO3
アイテム
{"_buckets": {"deposit": "c03bd4dc-6155-4d11-b2b5-12874c152279"}, "_deposit": {"created_by": 1, "id": "71873", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "71873"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00071873", "sets": ["28"]}, "author_link": ["707812", "707795", "707817", "707798", "707808", "707801", "707793", "707791", "707787", "707813", "707804", "707802", "707794", "707800", "707807", "707797", "707809", "707789", "707814", "707803", "707815", "707792", "707811", "707818", "707805", "707816", "707790", "707788", "707796", "707810", "707799", "707806"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2015-11-09", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objectives: 2-((1E,3E)-4-(6-(11C-methylamino)pyridin-3-yl)buta-1,3-dienyl)\nbenzo[d]thiazol-6-ol ([11C]PBB3, Fig. 1) is a clinically useful PET probe for in vivo imaging of tau pathology in the brain. For the pharmacokinetic evaluation of [11C]PBB3, it is important to elucidate the characteristics of radiometabolites. In this study, we evaluated radiometabolite after injection of [11C]PBB3 in mice brain and plasma, identified the chemical structure of a major radiometabolite of [11C]PBB3, and proposed the metabolic pathway of [11C]PBB3. \nMethods: [11C]PBB3 was synthesized by reaction of the tert-butyldimethylsilyl desmethyl precursor with [11C]methyl iodide using potassium hydroxide as a base, followed by deprotection. [11C]PBB3 or carrier-added [11C]PBB3 was injected into a mouse for in vivo metabolite analysis. The chemical structure of a major radiometabolite was identified using radio-HPLC and LC–MS. Mouse and human liver microsomes and liver S9 samples were incubated with [11C]PBB3 in vitro, and its radiometabolite was analyzed using radio-HPLC. In silico prediction software was used to assist in the determination of the metabolite and metabolic pathway of [11C]PBB3. \nResults and discussion: In in vivo metabolite study, more than 70% of total radioactivity in the mouse brain homogenate at 5 min after injection represented the parent [11C]PBB3, despite its rapid metabolism in the plasma. Also, in vivo metabolite study using carrier-added [11C]PBB3 showed that the molecular weight of a major radiometabolite of [11C]PBB3, which was called as [11C]M2 (Fig. 1), was m/z 390 [M+H+]. In vitro metabolite study assisted by in silico prediction showed that [11C]M2, which was not generated by cytochrome P450 enzymes (CYPs), was generated by sulfated conjugation mediated by a sulfotransferase. Our data demonstrated that [11C]PBB3 was mainly metabolized to [11C]M2 by sulfate conjugation mediated by sulfotransferases, and a minor radiometabolite, [11C]M1 (Fig. 1), was yielded through oxidation mediated by CYPs. These results suggest that [11C]M2 may be retained in the plasma, recirculated throughout the whole body, and may gradually enter the brain notwithstanding its relatively high polarity.\nConclusion: [11C]PBB3 was rapidly decomposed to a polar radiolabeled metabolite in the plasma. The major radiometabolite, [11C]M2, was identified as a sulfated conjugate of [11C]PBB3. [11C]PBB3 was metabolized mainly by a sulfotransferase and subsidiary by CYPs.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "Ninth Japan-China Joint Seminar on Radiopharmaceutical Chemistry", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Hashimoto, Hiroki"}], "nameIdentifiers": [{"nameIdentifier": "707787", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawamura, Kazunori"}], "nameIdentifiers": [{"nameIdentifier": "707788", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takei, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "707789", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Igarashi, Nobuyuki"}], "nameIdentifiers": [{"nameIdentifier": "707790", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujishiro, Tomoya"}], "nameIdentifiers": [{"nameIdentifier": "707791", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shiomi, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "707792", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ryuji, Watanabe"}], "nameIdentifiers": [{"nameIdentifier": "707793", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Muto, Masatoshi"}], "nameIdentifiers": [{"nameIdentifier": "707794", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Furutsuka, Kenji"}], "nameIdentifiers": [{"nameIdentifier": "707795", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ito, Takehito"}], "nameIdentifiers": [{"nameIdentifier": "707796", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamasaki, Tomoteru"}], "nameIdentifiers": [{"nameIdentifier": "707797", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yui, Joji"}], "nameIdentifiers": [{"nameIdentifier": "707798", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nemoto, Kazuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "707799", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kimura, Yasuyuki"}], "nameIdentifiers": [{"nameIdentifier": "707800", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Higuchi, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "707801", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong"}], "nameIdentifiers": [{"nameIdentifier": "707802", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "橋本 裕輝", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707803", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "河村 和紀", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707804", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "武井 誠", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707805", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "五十嵐 延行", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707806", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤代 智也", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707807", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "潮見 聡", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707808", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "渡辺 竜二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707809", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "武藤 正敏", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707810", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "古塚 賢士", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707811", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "伊藤 岳人", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707812", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山崎 友照", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707813", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "由井 譲二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707814", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "根本 和義", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707815", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "木村 泰之", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707816", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "樋口 真人", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707817", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "張 明栄", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "707818", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "IN VIVO, IN VITRO, AND IN SILICO EVALUATION OF RADIOMETABOLITE OF [11C]PBB3 AS A CLINICALLY USEFUL PET PROBE FOR IMAGING OF TAU PATHOLOGY. ", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "IN VIVO, IN VITRO, AND IN SILICO EVALUATION OF RADIOMETABOLITE OF [11C]PBB3 AS A CLINICALLY USEFUL PET PROBE FOR IMAGING OF TAU PATHOLOGY. "}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/71873", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-11-25"}, "publish_date": "2015-11-25", "publish_status": "0", "recid": "71873", "relation": {}, "relation_version_is_last": true, "title": ["IN VIVO, IN VITRO, AND IN SILICO EVALUATION OF RADIOMETABOLITE OF [11C]PBB3 AS A CLINICALLY USEFUL PET PROBE FOR IMAGING OF TAU PATHOLOGY. "], "weko_shared_id": -1}
IN VIVO, IN VITRO, AND IN SILICO EVALUATION OF RADIOMETABOLITE OF [11C]PBB3 AS A CLINICALLY USEFUL PET PROBE FOR IMAGING OF TAU PATHOLOGY.
https://repo.qst.go.jp/records/71873
https://repo.qst.go.jp/records/718731a5b3350-d2b4-491b-a092-a364fc73fd37
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-11-25 | |||||
タイトル | ||||||
タイトル | IN VIVO, IN VITRO, AND IN SILICO EVALUATION OF RADIOMETABOLITE OF [11C]PBB3 AS A CLINICALLY USEFUL PET PROBE FOR IMAGING OF TAU PATHOLOGY. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Hashimoto, Hiroki
× Hashimoto, Hiroki× Kawamura, Kazunori× Takei, Makoto× Igarashi, Nobuyuki× Fujishiro, Tomoya× Shiomi, Satoshi× Ryuji, Watanabe× Muto, Masatoshi× Furutsuka, Kenji× Ito, Takehito× Yamasaki, Tomoteru× Yui, Joji× Nemoto, Kazuyoshi× Kimura, Yasuyuki× Higuchi, Makoto× Zhang, Ming-Rong× 橋本 裕輝× 河村 和紀× 武井 誠× 五十嵐 延行× 藤代 智也× 潮見 聡× 渡辺 竜二× 武藤 正敏× 古塚 賢士× 伊藤 岳人× 山崎 友照× 由井 譲二× 根本 和義× 木村 泰之× 樋口 真人× 張 明栄 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objectives: 2-((1E,3E)-4-(6-(11C-methylamino)pyridin-3-yl)buta-1,3-dienyl) benzo[d]thiazol-6-ol ([11C]PBB3, Fig. 1) is a clinically useful PET probe for in vivo imaging of tau pathology in the brain. For the pharmacokinetic evaluation of [11C]PBB3, it is important to elucidate the characteristics of radiometabolites. In this study, we evaluated radiometabolite after injection of [11C]PBB3 in mice brain and plasma, identified the chemical structure of a major radiometabolite of [11C]PBB3, and proposed the metabolic pathway of [11C]PBB3. Methods: [11C]PBB3 was synthesized by reaction of the tert-butyldimethylsilyl desmethyl precursor with [11C]methyl iodide using potassium hydroxide as a base, followed by deprotection. [11C]PBB3 or carrier-added [11C]PBB3 was injected into a mouse for in vivo metabolite analysis. The chemical structure of a major radiometabolite was identified using radio-HPLC and LC–MS. Mouse and human liver microsomes and liver S9 samples were incubated with [11C]PBB3 in vitro, and its radiometabolite was analyzed using radio-HPLC. In silico prediction software was used to assist in the determination of the metabolite and metabolic pathway of [11C]PBB3. Results and discussion: In in vivo metabolite study, more than 70% of total radioactivity in the mouse brain homogenate at 5 min after injection represented the parent [11C]PBB3, despite its rapid metabolism in the plasma. Also, in vivo metabolite study using carrier-added [11C]PBB3 showed that the molecular weight of a major radiometabolite of [11C]PBB3, which was called as [11C]M2 (Fig. 1), was m/z 390 [M+H+]. In vitro metabolite study assisted by in silico prediction showed that [11C]M2, which was not generated by cytochrome P450 enzymes (CYPs), was generated by sulfated conjugation mediated by a sulfotransferase. Our data demonstrated that [11C]PBB3 was mainly metabolized to [11C]M2 by sulfate conjugation mediated by sulfotransferases, and a minor radiometabolite, [11C]M1 (Fig. 1), was yielded through oxidation mediated by CYPs. These results suggest that [11C]M2 may be retained in the plasma, recirculated throughout the whole body, and may gradually enter the brain notwithstanding its relatively high polarity. Conclusion: [11C]PBB3 was rapidly decomposed to a polar radiolabeled metabolite in the plasma. The major radiometabolite, [11C]M2, was identified as a sulfated conjugate of [11C]PBB3. [11C]PBB3 was metabolized mainly by a sulfotransferase and subsidiary by CYPs. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Ninth Japan-China Joint Seminar on Radiopharmaceutical Chemistry | |||||
発表年月日 | ||||||
日付 | 2015-11-09 | |||||
日付タイプ | Issued |